| Product Code: ETC7741676 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Lumasiran Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Lumasiran Market - Industry Life Cycle |
3.4 Japan Lumasiran Market - Porter's Five Forces |
3.5 Japan Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Japan Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Japan Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Japan Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of RNA interference (RNAi) therapies in Japan |
4.2.2 Rising prevalence of rare genetic diseases, such as primary hyperoxaluria type 1 (PH1), which can be treated by lumasiran |
4.2.3 Supportive regulatory environment for orphan drugs in Japan |
4.3 Market Restraints |
4.3.1 High cost associated with lumasiran treatment |
4.3.2 Limited availability and accessibility of specialized healthcare facilities offering lumasiran therapy in Japan |
5 Japan Lumasiran Market Trends |
6 Japan Lumasiran Market, By Types |
6.1 Japan Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Japan Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Japan Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Japan Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Japan Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Japan Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Japan Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Japan Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Japan Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Japan Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Japan Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Japan Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Japan Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Japan Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Japan Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Japan Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Japan Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Japan Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Japan Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Japan Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Japan Lumasiran Market Import-Export Trade Statistics |
7.1 Japan Lumasiran Market Export to Major Countries |
7.2 Japan Lumasiran Market Imports from Major Countries |
8 Japan Lumasiran Market Key Performance Indicators |
8.1 Number of healthcare providers trained in administering lumasiran therapy |
8.2 Patient enrollment rates in clinical trials for lumasiran |
8.3 Government funding or grants allocated for research and development of RNAi therapies in Japan |
9 Japan Lumasiran Market - Opportunity Assessment |
9.1 Japan Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Japan Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Japan Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Japan Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Lumasiran Market - Competitive Landscape |
10.1 Japan Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Japan Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here